Blankert, B., & Kauffmann, J.-M. (2010). Electroanalytical methods as tools for predictive drug metabolism studies. In Reviews in Pharmaceutical & Biomedical Analysis (pp. 76-83). |
![]() ![]() | Wells, M., Hambye, S., & Blankert, B. (23 March 2023). Preliminary insight into the potential antiplasmodial activity and cytotoxicity of Bufo bufo and Incilius alvarius poison. Toxicon, 227, 107092. doi:10.1016/j.toxicon.2023.107092 ![]() |
![]() ![]() | Gossuin, Y., Duez, P., Blankert, B., Masson, C., Laurent, S., & Rousseau, C. (2023). Chapitre d'équation 1 Section 1NMR relaxometry to monitor chromium (VI) reduction by hydrogen peroxide, ascorbic acid and aluminum powder. Magnetic Resonance in Chemistry. doi:10.1002/mrc.5332 ![]() |
![]() ![]() | Wells, M., Hambye, S., & Blankert, B. (2023). Preliminary insight into the potential antiplasmodial activity and cytotoxicity of Bufo bufo and Incilius alvarius poison. Toxicon, 227. ![]() |
![]() ![]() | Wells, M., Fossepre, M., Hambye, S., Surin, M., & Blankert, B. (December 2022). Uncovering the antimalarial potential of toad venoms through a bioassay-guided fractionation process. International Journal for Parasitology: Drugs and Drug Resistance, 20, 97 - 107. doi:10.1016/j.ijpddr.2022.10.001 ![]() |
![]() ![]() | Loyez, M., Wells, M., Hambye, S., Hubinon, F., Blankert, B., Wattiez, R., & Caucheteur, C. (28 July 2021). PfHRP2 detection using plasmonic optrodes: performance analysis. Malaria Journal, 20 (332). ![]() |
![]() ![]() | Traore, O., Ouedraogo, A., Compaoré, M., Nikiema, K., Zombre, A., Kiendrebeogo, M., Blankert, B., & Duez, P. (16 November 2020). Social perceptions of malaria and diagnostic-driven malaria treatment in Burkina Faso. Heliyon, 6, 05553. doi:10.1016/j.heliyon.2020.e05553 ![]() |
![]() ![]() | Soumoy, L., Wells, M., Ahmad, N., Krayem, M., Ghanem, G., Hambye, S., Saussez, S., Blankert, B., & Journe, F. (2020). 'Toad Venom Antiproliferative Activities on Metastatic Melanoma: Bio-Guided Fractionation and Screening of the Compounds of Two Different Venoms'. Biology, (9), 218-234. ![]() |
![]() ![]() | Traore, O., Campaore, M., Okusa, P., Hubinon, F., Duez, P., Blankert, B., & Kiendrebeogo, M. (16 May 2020). Development and validation of an original magneto-chromatography device for the whole blood determination of hemozoin, the paramagnetic malaria pigment. Microchemical Journal, 157. ![]() |
![]() ![]() | Baroni, A., Neaga, I., Delbosc, N., Wells, M., Verdy, L., Ansseau, E., Vanden Eynde, J.-J., Belayew, A., Bodoki, E., Oprean, R., Hambye, S., & Blankert, B. (25 September 2019). Bioactive Aliphatic Polycarbonates Carrying Guanidinium Functions: An Innovative Approach for Myotonic Dystrophy Type 1 Therapy. ACS Omega, 4 (19), 18126 - 18135. doi:10.1021/acsomega.9b02034 ![]() |
![]() ![]() | Lenaerts, C., Wells, M., Hambye, S., & Blankert, B. (17 January 2019). Marinobufagenin extraction from Rhinella marina toad glands: alternative approaches for a systematized strategy. Journal of Separation Science, 42 (7), 1384 - 1392. doi:10.1002/jssc.201800879 ![]() |
![]() ![]() | Baroni, A., Vlaminck, L., Mespouille, L., Du Prez, F., Delbosc, N., & Blankert, B. (01 January 2019). TAD click chemistry on aliphatic polycarbonates : a first step toward tailor-made materials. Macromolecular Rapid Communications, 40 (1800743), 1-5. ![]() |
Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (17 May 2018). Revealing of endogenous Marinobufagin by an ultra-specific and sensitive UHPLC-MS/MS assay in pregnant women. Talanta, 187, 193-199. ![]() |
Neaga, I.-O., Hambye, S., Bodoki, E., Palmieri, C., Ansseau, E., Belayew, A., Oprean, R., & Blankert, B. (11 May 2018). Affinity capillary electrophoresis for identification of active drug candidates in myotonic dystrophy type 1. Analytical and Bioanalytical Chemistry, 410, 4495-4507. ![]() |
Helvenstein, M., Hambye, S., & Blankert, B. (04 April 2017). Hepatocyte-based flow analytical bioreactor for online xenobiotics metabolism bioprediction. Nanobiomedicine, 4, 1-11. ![]() |
![]() ![]() | Pardo, A., Josse, T., Mespouille, L., Blankert, B., Dubois, P., & Duez, P. (26 January 2017). Synthesis of Quercetin-imprinted Polymer Spherical Particles with Improved Ability to Capture Quercetin Analogues. Phytochemical Analysis, 28 (4), 289-296. doi:10.1002/pca.2674 ![]() |
![]() ![]() | Neaga, I.-O., Bodoki, E., Hambye, S., Blankert, B., & Oprean, R. (28 October 2016). Study of nucleic acid-ligand interactions by capillary electrophoretic techniques: A review. Talanta, 148, 247-256. ![]() |
Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (15 August 2016). Early prediction of preeclampsia risk assessment: analytical determination for marinobufagenin in pregnant women. Journal of Maternal-Fetal and Neonatal Medicine, 29, 18. ![]() |
![]() ![]() | Helvenstein, M., Stanicki, D., Laurent, S., & Blankert, B. (2015). Interaction between iron oxide nanoparticles and HepaRG cells: a preliminary In vitro evaluation. Journal of Nanomaterials. doi:10.1155/2015/463841 ![]() |
Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (09 July 2015). Marinobufagenin as a promising preeclampsia risk assessment marker: purification from toad venom and LC-MS identification in human plasma. Pregnancy Hypertension, 5 (3), 213-214. ![]() |
Fouad, M., Helvenstein, M., & Blankert, B. (2015). Ultra High Performance Liquid Chromatography Method for the Determination of Two Recently FDA Approved TKIs in Human Plasma Using Diode Array Detection. Journal of Analytical Methods in Chemistry. doi:10.1155/2015/215128 ![]() |
Berkers, J. H. M., C., V., O., G., B., B., Conotte, R., Blankert, B., S., J., H., V. P., & E., L. (01 April 2015). 778 MIR-141 expression in clear cell renal cell carcinoma is linked with augmented susceptibility to sunitinib therapy in vivo. European Urology Supplements, 14 (2), 778-e778. ![]() |
![]() ![]() | Nachtergael, A., Coulembier, O., Dubois, P., Helvenstein, M., Duez, P., Blankert, B., & Mespouille, L. (01 January 2015). Organocatalysis paradigm revisited : are metal-free catalysts really harmless ? Biomacromolecules, 16, 507-514. doi:10.1021/bm5015443 ![]() |
![]() ![]() | Pardo, A., Mespouille, L., Blankert, B., Trouillas, P., Surin, M., Dubois, P., & Duez, P. (27 August 2014). Quercetin-imprinted chromatographic sorbents revisited : optimization of synthesis and rebinding protocols for application to natural resources. Journal of Chromatography. A, 1364, 128-139. ![]() |
Helvenstein, M., Hambye, S., & Blankert, B. (07 July 2014). Determination of three tyrosine kinase inhibitors and one active metabolite by an identical and validated ultra-performance liquid chromatography-DAD method in human plasma. Current Pharmaceutical Analysis, 10, 161-168. ![]() |
Pardo, A., Mespouille, L., Blankert, B., Dubois, P., & Duez, P. (24 February 2014). Molecularly imprinted polymers: compromise between flexibility and rigidity for improving capture of template analogues. Chemistry, 20 (12), 3500-3509. ![]() |
Hambye, S., Helvenstein, M., Verdy, L., Kahvecioglu, Z. C., Conotte, R., Vanden Eynde, J.-J., Colet, J.-M., & Blankert, B. (10 February 2014). Ultra High Performance Liquid Chromatography method for the determination of Pentamidine and analog in rat biological fluids. Journal of Pharmaceutical and Biomedical Analysis, 95, 54-60. ![]() |
Lenaerts, C., Larcy, C., & Blankert, B. (01 June 2013). Analytical aspects of marinobufagenin and its applications in the diagnosis of preeclampsia. Pregnancy Hypertension, 3, 99. ![]() |
![]() ![]() | Lenaerts, C., Demeyer, M., Gerbaux, P., & Blankert, B. (01 January 2013). Analytical aspects of marinobufagenin. Clinica Chimica Acta, 421, 193-201. ![]() |
Pardo, A., Mespouille, L., Dubois, P., Duez, P., & Blankert, B. (13 April 2012). Targeted extraction of active compounds from natural products by molecularly imprinted polymers. Central European Journal of Chemistry, 10 ((3)), 751-765. ![]() |
Hambye, S., Stanicki, D., Colet, J.-M., Aliouat, E.-M., Vanden Eynde, J.-J., & Blankert, B. (26 October 2010). Three optimized and validated (using accuracy profiles) LC methods for the determination of pentamidine and new analogs in rat plasma. Talanta, 83, 832-839. ![]() |
![]() ![]() | Yu, D., Van Antwerpen, P., Patris, S., Blankert, B., & Kauffmann, J.-M. (01 July 2010). Enzyme Immobilized Magnetic Nanoparticles for in-line Capillary Electrophoresis and Drug Biotransformation Studies: Application to Paracetamol. Combinatorial Chemistry and High Throughput Screening, 13 (6), 455-460. ![]() |
Yu, D., Van Antwerpen, P., Patris, S., Blankert, B., & Kauffmann, J.-M. (01 June 2010). Enzyme Immobilized Magnetic Nanoparticles for in-line Capillary Electrophoresis and Drug Biotransformation Studies: Application to Paracetamol. Combinatorial Chemistry and High Throughput Screening, 13, 455-460. ![]() |
Yu, D., Blankert, B., & Kauffmann, J.-M. (07 July 2007). Development of amperometric horseradish peroxidase based biosensors for clozapine and for the screening of thiol compounds. Biosensors and Bioelectronics, 22, 2707-2711. ![]() |
Yu, D., Blankert, B., Bodoki, E., Bolo, S., Viré, J.-C., Sandulescu, R., Nomura, A., & Kauffmann, J.-M. (07 July 2006). Amperometric biosensor based on horseradish peroxidase immobilised magnetic microparticles. Sensors and Actuators. B, Chemical, 113, 749-754. ![]() |
Yu, D., Dominguez, O., Blankert, B., Sima, V., Sandulescu, R., Arcos, J., & Kauffmann, J.-M. (07 July 2006). peroxidase-based biosensor supported by nanoporous magnetic silica microparticles for acetaminophen biotransformation and inhibition studies. Electroanalysis, 18, 1637-1642. ![]() |
Kimbeni, T., Blankert, B., Kambu, O., Amighi, K., Nsangu, J., & Kauffmann, J.-M. (07 July 2006). Amodiaquine polymeric membrane electrode. Journal of Pharmaceutical and Biomedical Analysis, 41, 70-76. ![]() |
Elyacoubi, A., Zayed, S. I. M., Blankert, B., & Kauffmann, J.-M. (07 July 2006). Development of an amperometric enzymatic biosensor based on gold modified magnetic nanoporous microparticles. Electroanalysis, 18, 345-350. ![]() |
Blankert, B., Hayen, H., Suze, V. L., Karst, U., Bodoki, E., Lotrean, S., Sandulescu, R., Mora Diez, N., Dominguez, O., Arcos, J., & Kauffmann, J.-M. (07 July 2005). Electrochemical, chemical and enzymatic oxidations of phenothiazines. Electroanalysis, 17, 1501-1510. ![]() |
Yu, D., Blankert, B., Viré, J.-C., & Kauffmann, J.-M. (07 July 2005). Biosensors in Drug Discovery and Drug Analysis. Analytical Letters, 38, 1687-1701. ![]() |
Suze, V. L., Blankert, B., Kauffmann, J.-M., & Karst, U. (07 July 2005). Prediction of clozapine metabolism by on-line electrochemistry/liquid chromatography/mass spectrometry. Analytical and Bioanalytical Chemistry, 382, 742-750. ![]() |
Blankert, B., Dominguez, O., El Ayyas, W., Arcos, J., & Kauffmann, J.-M. (07 May 2004). Horseradish peroxidase immobilised solid paraffin carbon paste electrode for the amperometric determination of clozapine. Analytical Letters, 37, 917-928. ![]() |
Serradilla-Razola, S., Blankert, B., Quarin, G., & Kauffmann, J.-M. (01 May 2003). Phenothiazine drugs as redox mediators in horseradish peroxidase bioelectrocatalysis. Analytical Letters, 36, 1819-1833. ![]() |
![]() ![]() | Loyez, M., Wells, M., Hambÿe, S., Hubinon, F., Blankert, B., Wattiez, R., & Caucheteur, C. (17 May 2022). PfHRP2 detection using plasmonic optical fibers: a step towards early malaria diagnosis. Proceedings of SPIE: The International Society for Optical Engineering, 12139. ![]() |
Leveque, M., Hambye, S., & Blankert, B. (28 May 2023). Quantification of affinity constants between small molecules and RNA probes representative of steinert’s disease by affinity capillary electrophoresis. Paper presented at 21st FORUM OF PHARMACEUTICAL SCIENCES. ![]() |
Leveque, M., Hambye, S., & Blankert, B. (13 September 2022). Identification of new therapeutic candidates targeting representative RNA probes of Steinert’s disease by affinity capillary electrophoresis. Paper presented at 12th International Symposium on Drug Analysis & 32nd International Symposium on Pharmaceutical and Biomedical Analysis, Mons, Belgium. ![]() |
Wells, M., Hambye, S., & Blankert, B. (12 September 2022). Development of a bioassay-guided fractionation protocol to unveil toad venoms as a new source of potential antimalarial candidates. Paper presented at 12th International Symposium of Drug Analysis 32nd International Symposium on Pharmaceutical and Biomedical Analysis, Mons, Belgium. ![]() |
Traore, O., Compaoré, M., Hubinon, F., Okusa, P., Duez, P., Blankert, B., & Kiendrebeogo, M. (26 October 2021). Diagnostic de la malaria: développement d'une méthode innovante de quantification du pigment malarique. Paper presented at XIIIème Edition du Forum national de la Recherche Scientifique et des Innovations Technologiques (FRSIT), Ouagadougou, Burkina Faso. ![]() |
Wells, M., Hambye, S., & Blankert, B. (14 September 2021). Identifying new potential antimalarial compound in toad venoms through a bio-guided fractionation process. Paper presented at 1st Congress of the European Venom Network EUVEN. ![]() |
Wells, M., Hambye, S., & Blankert, B. (17 September 2020). Discovery strategies for novel antiplasmodial compounds from the venom of Bufo toads. Paper presented at Venoms and Toxins, Oxford, United Kingdom. ![]() |
Wells, M., Soumoy, L., Journe, F., Saussez, S., Hambye, S., & Blankert, B. (04 December 2019). Bio-guided fractionation for the isolation of antiplasmodial and cytotoxic compounds from the venom of Bufo toads. Paper presented at 26ème RT-SFET, Paris, France. ![]() |
Lenaerts, C., Wells, M., Hambye, S., & Blankert, B. (12 September 2018). Quantification of endogenous marinobufagin by a high-specific and very sensitive UPLC-MS/MS assay in non-patological pregnancy and preeclampsia. Paper presented at DA-PBA 2018 : 11th International symposium on Drug Analysis - 29th International Symposium on Pharmaceutical and Biomedical Analysis, Leuven, Belgium. ![]() |
Romoaldo, G., Hambye, S., Tagliatti, V., Colet, J.-M., & Blankert, B. (12 September 2018). Assessing emotional states.: Metabonomic profiling and quantification of a salivary biomarker. Paper presented at DA-PBA 2018 : 11th International symposium on Drug Analysis - 29th International Symposium on Pharmaceutical and Biomedical Analysis, Leuven, Belgium. ![]() |
Neaga, I.-O., Hambye, S., Baroni, A., Bodoki, E., Blankert, B., & Oprean, R. (25 June 2018). Screening drug candidates for myotonic dystrophy type 1: nucleic acid probe design and method development. Paper presented at 18th CEEPUS Symposium and Summer School on Bioanalysis 2018, 25 - 30 June, Komarno, Slovakia. ![]() |
Baroni, A., Blankert, B., & Mespouille, L. (20 October 2017). TAD click-chemistry onto Aliphatic PolyCarbonates - A promising platform for tailor-made drug delivery. Paper presented at GEMO 2017, Gand, Belgium. ![]() |
Traore, O., Okusa, P. N., Compaoré, M., Duez, P., Blankert, B., & Kiendrebeogo, M. (17 October 2017). Développement d'un dispositif micro-fluidique magnétique pour le diagnostic de la malaria : modélisation et validation physico-chimique du procédé. Paper presented at 1er Congrès Scientifique International de la SOPHATOX-BURKINA, Ouagadougou, Burkina Faso. ![]() |
Neaga, I.-O., Bodoki, E., Hambye, S., Blankert, B., & Oprean, R. (06 July 2016). Characterization of oligonucleotides-ligand interactions with implications in myotonic dystrophy. Paper presented at 16th CEEPUS Symposium and Summer School on Bioanalysis, Warsaw, Unknown/unspecified. ![]() |
Lenaerts, C., Tuytten, R., Bond, L., Delporte, C., Van Antwerpen, P., & Blankert, B. (06 July 2016). A LC-MS assay for identification and quantification of marinobufagenin in human: a novel approach for preeclampsia risk evaluation. Paper presented at MASCL, Salzburg, Austria. ![]() |
Lenaerts, C., Tuytten, R., Bond, L., Delporte, C., Van Antwerpen, P., & Blankert, B. (12 May 2016). Early prediction of preeclampsia risk assessment: analytical determination for marinobufagenin in pregnant women. Paper presented at Second International Congress on Maternal Hemodynamics, Rome, Italy. ![]() |
Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (24 September 2015). Marinobufagenin as a promising preeclampsia risk assessment marker: purification from toad venom and LC-MS identification in human plasma. Paper presented at ISSHP (International Society for the Study of Hypertension in Pregnancy) 2015, Budapest, Hungary. ![]() |
Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (13 July 2015). Marinobufagenin as a potential biomarker for preeclampsia risk assessment: purification from Bufo Marinus toad venom as support for a human plasma LC-MS/MS assay. Paper presented at Joint meeting of the GP-TCM Research Association, the TCM Chemistry Specialty Committee and the TCM Pharmaceutical Analysis Specialty Committee of the World Federation of Chinese Medicine Societies, Mons, Belgium. ![]() |
![]() ![]() | Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (17 October 2014). Analysis of marinobufagenin in plasma for preeclampsia risk assessment: a promising early predictive tool. Paper presented at 1st International Congress on Maternal Hemodynamics, Hasselt, Belgium. ![]() |
Mespouille, L., Pardo, A., Duez, P., Blankert, B., & Dubois, P. (22 August 2013). Compromise between flexibility and rigidity in molecularly imprinted. Paper presented at 10th International Conference on Advanced Polymers via Macromolecular Engineering, Durham, United Kingdom. ![]() |
Hambye, S., Kauffmann, J.-M., & Blankert, B. (06 June 2009). 'On-line electrochemistry/mass spectrometry: tools of high potentiality for predictive drug biotransformation studies.'. Paper presented at Pre-satellite meeting PharmSciFair '09 (Young Pharmaceutical Scientists), Nice, France. ![]() |
Blankert, B., Van leeuwen, S. M., Karst, U., & Kauffmann, J.-M. (15 July 2007). Couplage de Techniques LC/EC/MS : ouitls de haute potentialité pour l'étude prédictive de la biotransformation de composés d'intérêt pharmaceutique. Paper presented at Journée d'Electrochimie, Lyon, France. ![]() |
Kauffmann, J.-M., & Blankert, B. (15 July 2007). Hyphenated electroanalytical methods as 'in vitro' tools for predictive drug metabolisation studies. Paper presented at 8th International Symposium on Pharmaceutical Sciences, Ankara, Turkey. ![]() |
Suze, V. L., Blankert, B., Kauffmann, J.-M., & Karst, U. (15 March 2006). On-line Electrochemistry/Liquid Chromatography/Mass Spectrometry for Prediction of Clozapine metabolism. Paper presented at Pittcon, Orlando, United States - Florida. ![]() |
Yu, D., Blankert, B., & Kauffmann, J.-M. (15 March 2006). Nanoporous magnetic silica particles for enzymes immobilized biosensors and microbioreactors. Paper presented at Pittcon, Orlando, United States - Florida. ![]() |
Suze, V. L., Blankert, B., Kauffmann, J.-M., & Karst, U. (15 February 2006). Electrochemistry/liquid chromatography/mass spectrometry for prediction of clozapine phase I and II metabolism. Paper presented at Ninth International Symposium on Hyphenated Techniques in Chromatography, York, United Kingdom. ![]() |
Soumoy, L., Wells, M., Najem, A., Krayem, M., Ghanem, G., Hambye, S., Saussez, S., Blankert, B., & Journe, F. (12 September 2022). Uncovering the antiproliferative potential of toad venoms on metastatic melanoma. Poster session presented at 12th International Symposium of Drug Analysis 32nd International Symposium on Pharmaceutical and Biomedical Analysis, Mons, Belgium. ![]() |
Wells, M., Hambye, S., & Blankert, B. (05 October 2021). Développement d'une stratégie de fractionnement bio-guidé pour l'identification de composés antiplasmodiaux issus de venins de Bufonidae. Poster session presented at 14ème Congrès Francophone sur les Sciences Séparatives et les Couplages de l'AFSEP, Paris, France. ![]() |
![]() ![]() | Gossuin, Y., Laurent, S., Masson, C., Duez, P., & Blankert, B. (01 July 2021). Following chromium (IV) reduction by low resolution nuclear magnetic relaxometry. Poster session presented at euromar. ![]() |
![]() ![]() | Duez, P., Roch, A., Blankert, B., Okusa, P. N., & Avaert, R. (06 May 2016). Malaria Detection: Pub. No. WO/2016/066754; International Application No PCT/EP2015/075144; Publication Date 06.05.2016; International Filing Date 29.10.2015. |